Topical insulin for refractory persistent corneal epithelial defects.

David Diaz-ValleBarbara Burgos-BlascoJose A Gegundez-FernandezSara Garcia-CarideVirginia Puebla-GarciaPilar Peña-UrbinaJose M Benitez-Del-Castillo

Published in: European journal of ophthalmology (2020)

Topical insulin can promote and accelerate corneal reepithelization of refractory PEDs. It also offers many other advantages, including excellent tolerance, availability, and cost-effectiveness.

Keyphrases

wound healing
type diabetes
glycemic control
optical coherence tomography
cataract surgery
metabolic syndrome
adipose tissue